B of A Securities Downgrades Amrize (AMRZ)
JP Morgan Downgrades Amrize (AMRZ)
JP Morgan Downgrades Amrize to Neutral, Lowers Price Target to $52
B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40
DA Davidson Initiates Coverage of Amrize (AMRZ) with Neutral Recommendation
DA Davidson Initiates Coverage On Amrize with Neutral Rating, Announces Price Target of $50
Amrize Appoints Samuel J. Poletti CFO, Effective Immediately, Succeeding Baris Oran
Amrize (AMRZ) Q2 2026 Earnings Call Transcript
Stephens & Co. Maintains Overweight on Amrize, Lowers Price Target to $54
Citigroup Maintains Buy on Amrize, Lowers Price Target to $58
RBC Capital Downgrades Amrize (AMRZ)
Amrize Files Form 10-Q for Second Quarter 2026
Amrize's Q2 Earnings Miss, EBITDA Guidance Cut Raise Execution Concerns, RBC Capital Markets Says
RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48
Has Amrize (SWX:AMRZ) Fallen Far Enough To Look Undervalued?
Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
Amrize Q2 Earnings Call Highlights
Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Amid Cost Headwinds
Amrize AG (AMRZ) Q2 2026 Earnings Call Transcript
Amrize Ltd Q2 2026 Earnings Call Summary
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.